A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Tiaprofenic acid
Benfluorex
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Benfluorex.
Tiaprofenic acid
Glibornuride
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Glibornuride.
Tiaprofenic acid
Gosogliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Gosogliptin.
Tiaprofenic acid
Liraglutide
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Liraglutide.
Tiaprofenic acid
Alogliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Alogliptin.
Tiaprofenic acid
Bisegliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Bisegliptin.
Tiaprofenic acid
AMG-222
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with AMG-222.
Tiaprofenic acid
NBI-6024
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with NBI-6024.
Tiaprofenic acid
NN344
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with NN344.
Tiaprofenic acid
Voglibose
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Voglibose.
Tiaprofenic acid
Vildagliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Vildagliptin.
Tiaprofenic acid
AICA ribonucleotide
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with AICA ribonucleotide.
Tiaprofenic acid
Segesterone acetate
The metabolism of Segesterone acetate can be increased when combined with Hydrocortisone valerate.
Probucol
Satralizumab
The serum concentration of Hydrocortisone probutate can be decreased when it is combined with Satralizumab.
Probucol
Oliceridine
The serum concentration of Oliceridine can be decreased when it is combined with Hydrocortisone probutate.
Probucol
Abametapir
The serum concentration of Hydrocortisone probutate can be increased when it is combined with Abametapir.
Probucol
Inebilizumab
The risk or severity of infection can be increased when Hydrocortisone probutate is combined with Inebilizumab.
Probucol
Selpercatinib
The serum concentration of Selpercatinib can be decreased when it is combined with Hydrocortisone probutate.
Probucol
Cyclopenthiazide
The risk or severity of electrolyte imbalance can be increased when Hydrocortisone probutate is combined with Cyclopenthiazide.
Probucol
Mebutizide
The risk or severity of electrolyte imbalance can be increased when Hydrocortisone probutate is combined with Mebutizide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3